Condition
Stage IV Bladder Cancer AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Stage IV Bladder Cancer AJCC v8 clinical trials that are recruiting, at sites in 2 countries (most in United States (6), Puerto Rico (1)). By phase: Phase 2 (3), Phase 1/2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Stage IV Bladder Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Enfortumab Vedotin, Pembrolizumab, and Quemliclustat for unresectable or metastatic urothelial cancer | Phase 1/2 | Seattle, Washington | Recruiting | Jun 25, 2026 |
| Consolidative therapy after initial response in advanced bladder cancer | Phase 1/2 | Seattle, Washington | Recruiting | May 12, 2026 |
| Combination of Enfortumab Vedotin and Pembrolizumab with Surgery for Advanced Bladder Cancer | Phase 4 | Rochester, Minnesota | Recruiting | Jan 8, 2025 |
| Using pemetrexed to treat metastatic bladder cancer and other solid tumors with specific gene mutations | Phase 2 | Chicago, Illinois and 1 other locations | Recruiting | Oct 8, 2024 |
| Combination treatment for advanced bladder cancer | Phase 2 | Atlanta, Georgia and 3 other locations | Recruiting | Mar 6, 2023 |
| Combining immunotherapy and targeted therapy for rare bladder tumors | Phase 2 | Birmingham, Alabama and 581 other locations | Recruiting | Mar 7, 2019 |
All recruiting trials (6)
-
Enfortumab Vedotin, Pembrolizumab, and Quemliclustat for unresectable or metastatic urothelial cancer
This trial tests a three-drug combination to see if it can safely treat unresectable or metastatic urothelial cancer in adults.
-
Consolidative therapy after initial response in advanced bladder cancer
This pilot trial tests adding radiation or surgery after a good response to EV + pembrolizumab in unresectable or oligometastatic muscle-invasive bladder cancer to see if residual disease can be eliminated or delayed from growing.
-
Combination of Enfortumab Vedotin and Pembrolizumab with Surgery for Advanced Bladder Cancer
This study is testing if a combination of two medications, enfortumab vedotin and pembrolizumab, can help people with advanced bladder cancer before they have surgery.
-
Using pemetrexed to treat metastatic bladder cancer and other solid tumors with specific gene mutations
This study is testing if the drug pemetrexed can help people with advanced bladder cancer and other solid tumors that have certain gene mutations.
-
Combination treatment for advanced bladder cancer
This study is testing a new combination of two treatments for people with advanced bladder cancer to see if it helps them respond better and live longer.
-
Combining immunotherapy and targeted therapy for rare bladder tumors
This study is testing a new combination of treatments for people with rare bladder tumors that have spread, to see if it helps them live longer and feel better.
Related topics
Quick answers
How many Stage IV Bladder Cancer AJCC v8 clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (6 trials), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.